1.
Badea CT,
Athreya KK,
Espinosa G,
Clark D,
Ghafoori AP,
Li Y,
Kirsch DG,
Johson GA,
Annapragada A,
Ghaghada KB (2012) Computed Tomography Imaging of Primary Lung Cancer in Mice Using a Liposomal-Iodinated Contrast Agent,
PLoS One.
[online] 7(4): e34496.
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317632/ [Published online Apr 2,
2012]
2.
Shilo M,
Reuveni T,
Motiei M,
Popovtzer R (2012) Nanoparticles as computed tomography contrast agents:current status and future perspectives.
Nanomedicine(Lond). 7(2).
p.
257-69
3.Lee N,
Choi SH,
Hyeon T.
(2014) Nano-sized CT contrast agents.
Advanced Materials (Deerfield Beach,
Fla.). 25(19).
p.
2641-60
4.Anton N.,
Vandamme TF.
(2014) Nanotechnology for computed tomography: a real potential recently disclosed.
Pharmaceutical Research 31(1).
p.
20-34
5.Lusic H,
Grinstaff MW.
(2013) X-ray-computed tomography contrast agents.
Chemical Reviews 113(3):1641-66.
6.Jokerst JV,
Lobovkina T,
Zare RN,
Gambhir SS.
(2011) Nanoparticle PEGylation for imaging and therapy.
Nanomedicine (Lond). 6(4).
p.
715-28
7.Charles L,
Attama AA.
(2011) Current State of Nanoemulsions in Drug Delivery.
Journal of Biomaterials and Nanobiotechnology. 2.
p 626-639.
8.Joh DY,
Sun L,
Stangl M,
Al Zaki A,
Murty S,
Santoiemma PP,
Davis JJ,
Baumann BC,
Alonso-Basanta M,
Bhang D,
Kao GD,
Tsourkas A,Dorsey JF.
(2013) Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization PloS One [Online] 8(4):e62425.
Available from:http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0062425 [published online
9.Albertazzi L,
Brondi M,
Pavan GM,
Sato SS,
Signore G,
Storti B,
Ratto GN,
Beltram F.
Dendrimer-based fluorescent indicators: in vitro and in vivo applications.
Plos One [Online] (2011) 6(12):e28450 Available from: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0028450 [published online: Dec 7 2011]